Pediatric Endocrinology Diabetes and Metabolism

Abstract

3/2021 vol. 27
Original paper

The incidence rate of hospitalized lysosomal storage diseases in Poland in 2013-2015 based on data from the National Health Fund

  1. Chair and Department of Internal Medicine, Diabetology, and Nephrology, Silesian University of Medicine, Zabrze, Poland
  2. The Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland
  3. Department of Internal Diseases, Endocrinology and Nephrology, Central Clinical Hospital of the Ministry of Interior Affairs and Administration, Warsaw, Poland
  4. Department of Paediatrics, Medical University of Warsaw, Warsaw, Poland
  5. Department of Research and Development and Innovative Medicine for Metabolic Diseases at the Diabetic Clinic, Nysa, Poland
  6. Department of Analyses and Strategy, Ministry of Health, Warsaw, Poland
  7. Social Insurance Department of the Warsaw School of Economics, Warsaw, Poland
Pediatr Endocrinol Diabetes Metab 2021; 27 (3): 191–198
Online publish date: 2021/08/28
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

The reported data address the incidence of lysosomal storage diseases, obtained from the public health service databases in Poland. Data are given by subtypes from the National Health Fund between 2013 and 2015.

Material and methods

Patients with lysosomal storage diseases were identified in the National Health Fund database (2013–2015). In order to ensure that the reported incidence data included only new patients. The geographic area of residence in 2013–2015 was divided into 6 parts.

Results

The incidence rate of lysosomal storage diseases in Poland is about 1.84/1 million/person/years. Other sphingolipidosis was the largest disease category, with 127 patients (incidence 1.1 patients/million habitants), follow by GM2 gangliosidosis – 29 patients (incidence 0.25 patients/million habitants). Men had a somewhat higher incidence than women (respectively IR = 2.53, IR = 1.84). The number of deaths with lysosomal storage disease patients hospitalized between the years 2013 through 2015 is higher in young people (0–9 years old).

Conclusions

The incidence rate of lysosomal storage diseases in Poland is about 1.84 per million person-years. Other sphingolipidosis was the largest disease category, followed by GM2 gangliosidosis. The hospitalization rate of lysosomal storage diseases was higher in men.

Share
without publication fees